Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-08
DOI
10.1038/s41598-020-63276-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity
- (2019) Kevin H. Lin et al. Cell Metabolism
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- The mechanism of cancer cell death by PARP inhibitors goes beyond DNA damage alone
- (2019) Antonio Macciò et al. INTERNATIONAL JOURNAL OF CANCER
- Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity
- (2019) Javier Mora et al. Cells
- Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.
- (2018) Clelia Madeddu et al. HAEMATOLOGICA
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.
- (2018) Clelia Madeddu et al. HAEMATOLOGICA
- Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
- (2018) Ignace Vergote et al. LANCET ONCOLOGY
- Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis
- (2018) Sarada Preeta Kalainayakan et al. Cell and Bioscience
- Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation
- (2017) Untack Cho et al. MOLECULAR CARCINOGENESIS
- The Heme Connection: Linking Erythrocytes and Macrophage Biology
- (2017) Md Zahidul Alam et al. Frontiers in Immunology
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease
- (2015) F. Vinchi et al. BLOOD
- Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer
- (2015) Vincenzo Bronte et al. NATURE MEDICINE
- A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
- (2014) Meiying Zhang et al. Journal of Ovarian Research
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Cisplatin: an old drug with a newfound efficacy – from mechanisms of action to cytotoxicity
- (2013) Antonio Macciò et al. EXPERT OPINION ON PHARMACOTHERAPY
- The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications—a review
- (2013) Antonio Macciò et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- Development of Human Single-Chain Antibodies to the Transferrin Receptor that Effectively Antagonize the Growth of Leukemias and Lymphomas
- (2010) R. Crepin et al. CANCER RESEARCH
- Synthetic and natural iron chelators: therapeutic potential and clinical use
- (2009) Heather C Hatcher et al. Future Medicinal Chemistry
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started